Project Grant HT94252510462
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$250K
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
This $249,986 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by The University of Texas Southwestern Medical Center (UT Southwestern) to understand genetic determinants of multiple sclerosis (MS) progression using longitudinal cohorts. The two-year grant, awarded on September 1, 2024, will enable UT Southwestern to conduct advanced biomedical research focused on transforming...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
This $1,675,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Yale University aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Drug Discovery for Dystonia and Frontotemporal Degeneration," will be conducted over a 4-year period from August 2025 to August 2029. The work at Yale University is expected...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
The federal Project Grant award of $999,965.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Yale University to investigate the role of the TDP-43 protein in trauma-associated Alzheimer's disease related dementia. The project aims to advance understanding of the protein dynamics underlying this condition, with the potential to transform healthcare for military service members, veterans, and the broader...
This federal Project Grant award for $859,773.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Yale University aimed at transforming healthcare for military service members, veterans, and the broader public. The research project focuses on investigating biomarkers and targets of leptomeningeal disease progression from non-small cell lung cancer brain metastasis. The award has a performance...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...